According to Heidelberg Pharma's latest financial reports the company's current revenue (TTM ) is ยฃ7.37 Million. In 2023 the company made a revenue of ยฃ8.38 Million a decrease over the revenue in the year 2022 that were of ยฃ16.17 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.